This news isn’t hard to swallow. Researchers at Yale University have identified a low-cost prescription drug already on the market that could help ease symptoms of autism spectrum disorder (ASD) in some people. And if you’re thinking it’s leucovorin — a vitamin B–derived drug hyped as a possible remedy — you’d be wrong. Approximately 1 … Read more
Last week, researchers dropped a bombshell report on DFNZ, a developing new medicine derived from a class of drugs once considered too dangerous to even study. Their proposal sounded almost too good to be true: The drug might offer patients with chronic pain and injuries the benefits of an opioid without the threat of addiction … Read more
Just think, we may have never gotten the “Oh, oh, oh, Ozempic!” jingle stuck in our heads if it wasn’t for a creepy, bottom-dwelling fish. Dr. Joel Habener of Massachusetts General Hospital unexpectedly discovered GLP-1 in the 1980s while analyzing the pancreatic genes in anglerfish. Habener’s team identified the precursor to GLP-1, a hormone that regulates … Read more
Mane justice. For sufferers of hair loss, patience for the two most commonly prescribed pharmaceuticals — and their well-documented side effects — is wearing thin. But new research points to old wisdom for how to treat a thinning a hairline, offering a gentler and more natural alternative to the pills and foams stocked in the … Read more
*Gulp* Much to the relief of the needle-shy, the FDA has just approved a second oral GLP-1 drug, following the release of the semaglutide Wegovy pill in January. But this new tablet, from pharma giant Eli Lilly, promises to be even more convenient than its predecessor with similar, if slightly less drastic, weight-trimming results. The … Read more
More good news in the battle against opioid addiction. Scientists have reopened research into a class of opioids that were once shelved from study — and have discovered a variant that’s a powerful pain reliever, but potentially much safer for sustained use. Though research into nitazenes, a long-overlooked synthetic opioid compound, was cut short in … Read more
G whiz! The latest experimental GLP-1 from Eli Lilly isn’t just a diabetes drug — it also facilitates weight loss. Known as “triple-G,” injectable retatrutide levies a triple whammy on the GLP-1, GIP and glucagon hormones, whereas most other drugs on the market only mimic one or two of those hormones. Eli Lilly’s new retatrutide drug … Read more
Tiger Woods allegedly had two hydrocodone pills in his left pant pocket when he flipped his Land Rover in Florida and was subsequently arrested on DUI charges last Friday. While the drug is prescribed to treat chronic pain or manage pain after surgery or injury, using it is not without risks — and serious ones at … Read more
Indiana Jones’ greatest fear may be obesity’s biggest enemy. Scientists at three universities have turned to nature to find a property that rivals the benefits of GLP-1 drugs without the laundry list of side effects. What they’ve discovered, in the cold blood of a creature that grows up to 33 feet long, is poised to … Read more
The GLP-1 PR has been a little too good. Everyone knows the drugs lead to rapid weight loss — including participants in supposedly “blind” drug trials. So now, when those participants don’t drop pounds, they drop out. Pharmaceutical manufacturers are reporting widespread instances of patients quitting their clinical trials prematurely once they realize they’ve been … Read more
The weight-loss world is on the brink of a major shake-up. Pharmaceutical companies in India will get the green light this weekend to start selling generic versions of Ozempic and Wegovy, with several other countries set to follow in the months ahead. The move is expected to unleash a wave of cheaper alternatives, dramatically widening … Read more
Welcome to The Thin Line, the New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks. Check back for more stories about the lesser-known downsides of … Read more
Six years after the start of the COVID-19 pandemic, its effects are still visible — from widespread hybrid work schedules to declining student performance. Add another wrinkle to the list — new prescriptions for ADHD medicine have more than doubled since the start of the pandemic, especially among younger adults. ADHD, or attention-deficit/hyperactivity disorder, is … Read more
You’ve heard of the little blue pill. Now, a new documentary is turning the spotlight on the pink one. Men have had pharmaceutical options for erectile dysfunction for decades — Viagra and Cialis are just a few. But a female libido pill has been more elusive. Enter Addyi. Addyi has undergone a few makeovers before … Read more
After getting engaged, the only words journalist Mrinali Dhembla expected to hear were “I do.” Instead, she was told, “You have cancer.” “When I first heard the words, ‘You have cancer,’ I was obviously very shaken because when you’re in your 20s, you just think that a little disturbance in your bowels isn’t a big … Read more
Welcome to The Thin Line, The New York Post’s series about the darker side of GLP-1 drugs. Though GLP-1 agonists sold under brand names like Ozempic have helped millions of people lose weight, manage diabetes and improve other health conditions, they are not without risks. Check back for more stories about the lesser-known downsides of … Read more
That’s some serious star power! Shortly after his baffling Pizza Hut commercial dropped, ex-NFL star Tom Brady was named chief wellness officer of eMed, a digital health platform for GLP-1 drugs and more. The seven-time Super Bowl champion, 48, joins the ranks of superstar athletes promoting the blockbuster weight loss and diabetes meds, a head-scratching … Read more
Too good to be true? While blockbuster GLP-1 drugs continue to reach new heights in popularity, they’re not without potential downsides, like bizarre side effects such as “Ozempic feet.” And while they boast impressive blood sugar and weight loss results — average weight lost is nearly 10% over a year — making one mistake could … Read more
Your medication might start tattling on you if you skip a dose. Scientists at MIT have developed a groundbreaking smart pill that can wirelessly report the moment it’s been swallowed, giving doctors a way to monitor whether patients are taking their prescriptions on schedule. It may sound simple, but the stakes are high. Studies show … Read more
New York Post may be compensated and/or receive an affiliate commission if you click or buy through our links. Featured pricing is subject to change. With weight loss drugs taking the world by storm, more people are exploring adding these medical marvels to their toolkits. Aside from the impressive results, GLP-1s seem to be increasingly … Read more